Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?". Issue 3 (March 2021)

Record Type:: Journal Article
Title:: Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?". Issue 3 (March 2021)
Main Title:: Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?"
Authors:: Zelber-Sagi, Shira
Schonmann, Yochai
Yeshua, Hanny
Bentov, Itay
Abstract:
Is Part Of:: Digestive and liver disease. Volume 53:Issue 3(2021)
Journal:: Digestive and liver disease
Issue:: Volume 53:Issue 3(2021)
Issue Display:: Volume 53, Issue 3 (2021)
Year:: 2021
Volume:: 53
Issue:: 3
Issue Sort Value:: 2021-0053-0003-0000
Page Start:: 385
Page End:: 386
Publication Date:: 2021-03
Subjects:: Cardiovascular -- Fibrosis marker -- Primary prevention -- NAFLD -- Primary care
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.dld.2021.01.014 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 22954.xml